Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Impax gets FDA OK for prostate drug
Bizjournals.com
Tuesday, March 2, 2010 - 10:47am
tags:
Impax, FDA, Flomax
AstraZeneca Chief Talks Pharma Challenges
Businessweek
Tuesday, March 2, 2010 - 10:46am
tags:
David Brennan, AstraZeneca, Pharma CEOs
Hedge Funds Heart Pfizer
NY Times, NY
Tuesday, March 2, 2010 - 10:45am
tags:
hedge funds, Pfizer
Connecticut AG Urges Curbs On Pharma Influence
Pharmalot
Tuesday, March 2, 2010 - 10:44am
tags:
Connecticut, physician gifts
Bayer's Birth-Control Problem Is Exploding: 1,100 Lawsuits Allege Yaz Causes Blood Clots
BNET Pharma
Tuesday, March 2, 2010 - 9:02am
tags:
Bayer, birth control pill, Yaz
Anthera IPO: Second Biotech to Price Low, but Price Isn't Everything
BNET Pharma
Tuesday, March 2, 2010 - 9:00am
tags:
IPOs, Anthera
Bristol-Myers: FDA panel clears a transplant drug Bristol-Myers: FDA panel clears a transplant drug
Marketwatch
Tuesday, March 2, 2010 - 8:47am
tags:
Bristol-Myers Squibb, FDA, transplant drugs, belatacept
Summary Box: Merck pays last $4.1B for Vioxx patient settlements, some other suits continue
Yahoo/AP
Tuesday, March 2, 2010 - 7:27am
tags:
Merck, Vioxx, settlements
UCB Drops After Forecasting 2010 Earnings Won’t Rise
Bloomberg
Tuesday, March 2, 2010 - 7:25am
tags:
UCB Pharmaceuticals, guidance, earnings
Astellas Sues OSI for Rejecting $3.5 Billion Offer
Bloomberg
Tuesday, March 2, 2010 - 7:24am
tags:
Astellas, lawsuits, M&A, OSI Pharmaceuticals
Summary Box: Merck-Drug Pipeline
Yahoo/AP
Tuesday, March 2, 2010 - 7:24am
tags:
Merck, pipelines
Elan execs get $8M in stock awards
Fierce Pharma
Monday, March 1, 2010 - 11:49am
tags:
Elan
Bristol-Myers Squibb: Looks Like a Good Value
Seeking Alpha
Monday, March 1, 2010 - 11:48am
tags:
Bristol-Myers Squibb
Should Generic Drugmakers Pay User Fees?
Pharmalot
Monday, March 1, 2010 - 11:01am
tags:
generics, user fees
OSI, Millipore takeover bids stoke biotech stocks
Marketwatch
Monday, March 1, 2010 - 11:00am
tags:
OSI Pharmaceuticals, Millipore, Astellas, drug stocks, M&A, Merck KGaA
Ariad cancer treatment gets 'orphan drug' status
Yahoo/AP
Monday, March 1, 2010 - 10:49am
tags:
orphan drugs, Ariad Pharmaceuticals, leukemia
Japan's Astellas bids $3.5 billion for OSI Pharma
Reuters
Monday, March 1, 2010 - 10:48am
tags:
OSI Pharmaceuticals, Astellas, M&A
Heart Association Finds Drug Risks "Inconclusive" After Taking $3.6M From Its Maker Glaxo
BNET Pharma
Monday, March 1, 2010 - 10:39am
tags:
Avandia, GSK, American Heart Association
Stronger Label for Biogen's Tysabri
Yahoo/Zacks.com
Monday, March 1, 2010 - 10:00am
tags:
Biogen Idec, Elan, Tysabri, multiple sclerosis
FDA accepts Vivus application for obesity drug
Marketwatch
Monday, March 1, 2010 - 9:57am
tags:
FDA, Vivus, obesity, Qnexa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.